Auswertung digitaler Bildaufnahmen der menschlichen Netzhaut im Rahmen klinischer Studien bzw. klinischer Forschung - Identifizierung, Charakterisierung und Annotation von krankheitsassoziierten Merkmalen zur Erforschung von innovativen Therapieansätzen und Biomarkern
Die ausgeschriebene Doktorandenstelle ist Teil des EU-geförderten, internationalen Verbundprojekts BATMAN (BOB1 as a therApeutic Target and bioMarker of AutoimmuNity to lymphoma progression), das auf die Validierung des Transkriptions-Koaktivators BOB1 als …
You will act as a go-to person in digital biomarkers and provide technical guidance to other project/study statisticians, stakeholders and junior staff … Provide profound insights into the other steps (content validity, analytic validity and usability) to define novel digital endpoints
Under the direction of the Herbert and ... Klein Alzheimer’s Research Center at the Brain Health Institute (BHI), Rutgers seeks a faculty level expert in fluid biomarkers for a tenure-track position at the associate or full professor level at BHI, and
Strong research and attractive study programmes attract researchers and students from around the world … The main purpose of this PhD project is to identify biomarkers that can be used for early detection, risk stratification, and potential therapeutic targeting in borderline serous ovarian tumors (BOTs)
With access to extensive multimodal datasets and expertise in clinical, digital-motor, and molecular outcome modeling, our group is dedicated to trial-relevant analyses. This is supported by a wet lab team employing advanced molecular biomarkers for stratification, progression, and target engagement; which directly feed into …
Provide scientific expertise and strategic guidance across all translational research programs. Lead the development and execution of biomarker strategies and early clinical development plans for designated programs. Develop and implement scientific strategies, with a focus on HBV research
We will establish combination therapies using preclinical in vitro and in vivo experimental models, which will be translated into clinical application in the near future. We will identify novel biomarkers based on mass cytometry and circulating DNA to distinguish the true "high-risk" patient population from the "low-to …
Unternehmen - Innovativ, dynamisch und nachhaltig: Als eines der weltweit führenden Unternehmen der forschenden Arzneimittelindustrie bieten wir bei AstraZeneca die besten Möglichkeiten für Ihre persönliche und berufliche Entwicklung … Unterstützung bei der Entwicklung der Produkt- und Kommunikationsstrategien zu …